Latest Articles

Publication Date
Natalie Githinji appeals to Ruto to support endometriosis patients - K24 Digital

Natalie Githinji appeals to Ruto to support endometriosis patients K24 Digital

Published: July 24, 2026, 7:17 a.m.
Allison Dussliere - Women's Health and Robotic Surgery, Patient Story - MercyOne

Allison Dussliere - Women's Health and Robotic Surgery, Patient Story MercyOne

Published: July 23, 2026, 6:51 p.m.
A network for the management of patients with endometriosis, integrated care, is being created in Lazio - Agenzia Nova

A network for the management of patients with endometriosis, integrated care, is being created in Lazio Agenzia Nova

Published: July 20, 2026, 5:32 p.m.
New ‘glowing’ technique could transform complex endometriosis surgery making it safer for patients - SussexWorld

New ‘glowing’ technique could transform complex endometriosis surgery making it safer for patients SussexWorld

Published: July 16, 2026, 11:29 a.m.
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - BioSpace

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy BioSpace

Published: July 15, 2026, 3:11 p.m.
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - Business Wire

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy Business Wire

Published: July 15, 2026, 10:45 a.m.
Merck’s 299-patient Keytruda trial meets PFS endpoint - grafa.com

Merck’s 299-patient Keytruda trial meets PFS endpoint grafa.com

Published: July 15, 2026, 8:07 a.m.
Mimicry in the Colon: Endometriosis-Associated Carcinoma in a Post-hysterectomy Patient - Cureus

Mimicry in the Colon: Endometriosis-Associated Carcinoma in a Post-hysterectomy Patient Cureus

Published: July 12, 2026, 10:26 p.m.
'Game-changer' for endometriosis patients as two new tests available on NHS - London Evening Standard

'Game-changer' for endometriosis patients as two new tests available on NHS London Evening Standard

Published: July 9, 2026, 8:41 p.m.
'Game-changer' for endometriosis patients as two new tests available on NHS - standard.co.uk

'Game-changer' for endometriosis patients as two new tests available on NHS standard.co.uk

Published: July 9, 2026, 8:41 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!